NCT00957268View on ClinicalTrials.gov

Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Alogliptin

Alogliptin tablets

Trial Locations (7)

Unknown

Miami

Pineallas Park

Louisville

Durham

Philadelphia

Memphis

San Antonio

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY